Figure 2 depicts the distributions of the concentrations of S-EGFR (2a), S-EGF (2b), S-HBEGF (2c), S-AREG (2d), S-TGFα (2e), and S-BTC (2f) in breast cancer patients and healthy controls, respectively. Here, BTC is linked to breast carcinoma.